Who is sponsoring NCT07288554?

NCT07288554 is sponsored by Bambusa Therapeutics.

What drugs are being tested in NCT07288554?

Interventions in NCT07288554: BBT002, Placebo.

What condition does NCT07288554 study?

NCT07288554 studies Chronic Obstructive Pulmonary Disease (COPD).

Is NCT07288554 still recruiting?

NCT07288554 is currently recruiting now. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT07288554

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Recruiting now Phase 1 Last updated 7 January 2026

What this trial tests

Phase 1 trial testing BBT002 in Chronic Obstructive Pulmonary Disease (COPD) in 68 participants. Currently enrolling.

Timeline

5 September 2025

Primary endpoint
31 December 2026

30 May 2027

Quick facts

Lead sponsor	Bambusa Therapeutics
Phase	Phase 1
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	triple
Primary purpose	treatment
Enrollment	68
Start date	5 September 2025
Primary completion	31 December 2026
Estimated completion	30 May 2027
Sites	11 locations across China

Drugs / interventions tested

BBT002 — full drug profile →
Placebo

Conditions studied

Chronic Obstructive Pulmonary Disease (COPD) — all drugs for Chronic Obstructive Pulmonary Disease (COPD) →

Sponsor

Bambusa Therapeutics — full company profile →

Who can join

Adults 18 to 75, any sex, with Chronic Obstructive Pulmonary Disease (COPD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants with Chronic Obstructive Pulmonary Disease (COPD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of BBT002

Trials testing the same drug.

NCT07436949 — A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and · Phase 1, PHASE2 · not yet recruiting
NCT06944925 — A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) · Phase 1 · recruiting

Other recruiting trials for Chronic Obstructive Pulmonary Disease (COPD)

Currently open trials in the same condition.

NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
NCT07355868 — Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy · EARLY_PHASE1 · recruiting
NCT06892210 — Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) · Phase 4 · recruiting
NCT07477600 — cfMSC Stem Cell Therapy Targeting COPD · Phase 1, PHASE2 · recruiting
NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting

Other Bambusa Therapeutics trials

Trials by the same sponsor.

NCT07436949 — A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and · Phase 1, PHASE2 · not yet recruiting
NCT07239947 — A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) · Phase 1 · recruiting
NCT06944925 — A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) · Phase 1 · recruiting
NCT06808477 — A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07288554 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bambusa Therapeutics
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07288554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing